Quantitative systems pharmacology Model to characterize valproic acid induced hyperammonemia and the effect of L carnitine supplementation ScienceDirect Novel Agents in the Management of Hepatic Encephalopathy: A Review Valproic Acid Toxicity When the calmer becomes the culprit In the ICU, some tox cases whisper and some unravel like a metabolic domino cascade. Valproate toxicity belongs to the latter. Frontiers What drives hyperammonemic encephalopathy in AED users: monotherapy risks or polypharmacy perils? Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid induced Hyperammonemia: A Rare Case Report Cureus Hyperammonaemia in Neonates and Young Children: Potential Metabolic Causes, Diagnostic Approaches and Clinical Consequences Irish Medical Journal